Cytokinetics has revealed the results from a phase 3 trial of its hypertrophic cardiomyopathy (HCM) drug aficamten that it hopes will allow it to compete with Bristol-Myers Squibb’s first-to-market ...
Cytokinetics, Incorporated CYTK announced that the European Commission (EC) has approved Myqorzo (aficamten), 5 mg, 10 mg, 15 mg and 20 mg tablets, for the treatment of adult patients with symptomatic ...
Thank you for standing by, and welcome to the Cytokinetics Fourth Quarter 2025 Earnings Call. This call is being recorded. [Operator Instructions] I would now like to turn the call over to Diane ...
Abstract: Diazepam is an active ingredient of the drugs which is used in the treatment of the anxiety, insomnia, alcohol withdrawal, and muscle spasm. It has anxiolytic, sedative, muscle relaxant and ...
1 Newborn Research Centre, The Royal Women's Hospital, Melbourne, Victoria, Australia 2 Neonatal Research, The Murdoch Childrens Research Institute, Melbourne, Victoria, Australia This was a ...
7 Royal Surrey County Hospital NHS Foundation Trust and Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results